| Tech Consultant Hylaine Presents at the Digital Insurance Summit on Building and Unifying Data, and Scaling Insurance Operations in the Cloud |
Globe Newswire |
05/11 |
08:00 |
| Enterprise AI Is Stalling: 46% of Initiatives Fall Short Despite Rising Investment |
Globe Newswire |
05/11 |
08:00 |
| Boost Run (“BRUN”) Begins Trading on Nasdaq with $940 Million of Contracted Customer Revenue |
Globe Newswire |
05/11 |
08:00 |
| Russia and Ukraine trade blame for continued fighting as US-brokered ceasefire nears its end |
AP Online |
05/11 |
07:54 |
| eXp World Holdings Reports Q1 2026 Results |
Globe Newswire |
05/11 |
07:45 |
| Inspira Technologies CEO Issues Letter to Shareholders on Strategic Direction and Value Creation Plan |
Globe Newswire |
05/11 |
07:31 |
| Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates |
Globe Newswire |
05/11 |
07:30 |
| ROE Dental Laboratory Becomes First U.S. Lab to Deploy an Extensive Fleet of 3D Systems Jetted-Denture Printing Systems Across Multiple Sites |
Globe Newswire |
05/11 |
07:30 |
| Quantum Leap Energy Enters into Memorandum of Understanding with European Nuclear Technology Company for Advanced Nuclear Fuel Supply Collaboration |
Globe Newswire |
05/11 |
07:30 |
| OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale |
Globe Newswire |
05/11 |
07:30 |
| Cronos Group Reports 2026 First Quarter Results |
Globe Newswire |
05/11 |
07:30 |
| Dyne Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights |
Globe Newswire |
05/11 |
07:30 |
| Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
05/11 |
07:30 |
| Encore Capital Group, Inc. Announces Proposed Senior Secured Notes Offering |
Globe Newswire |
05/11 |
07:17 |
| Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up |
Globe Newswire |
05/11 |
07:05 |
| IREN Announces Proposed Convertible Notes Offering |
Globe Newswire |
05/11 |
07:00 |
| Hain Celestial Reports Fiscal Third Quarter 2026 Financial Results |
Globe Newswire |
05/11 |
07:00 |
| Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program |
Globe Newswire |
05/11 |
07:00 |
| Keel Infrastructure Reports First Quarter 2026 Results |
Globe Newswire |
05/11 |
07:00 |
| Village Farms Reports Q1 2026 Results Driven by Record International Export Sales |
Globe Newswire |
05/11 |
07:00 |
| Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago |
Globe Newswire |
05/11 |
07:00 |
| Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab) |
Globe Newswire |
05/11 |
07:00 |
| Multi Ways Holdings Reports Fiscal Year 2025 Results: Revenue Grows 44% to $44.8 Million |
Globe Newswire |
05/11 |
07:00 |
| MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing |
Globe Newswire |
05/11 |
07:00 |
| Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update |
Globe Newswire |
05/11 |
07:00 |
